Home › Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research
 

Keywords :   


Cellular Dynamics Announces Agreement With AstraZeneca On Use Of iPSC-Derived Human Cells In Drug Discovery Research

2013-01-07 07:29:27| drugdiscoveryonline Home Page

Cellular Dynamics International, Inc. (CDI) recently announced a Center of Excellence agreement with AstraZeneca to accelerate the pace of drug discovery through the use of human induced pluripotent stem cell (iPSC) lines and tissue cells.

Tags: research agreement human drug

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
05.07Tropical Storm Beryl Potential Storm Surge Flooding Map
05.07Tropical Storm Beryl Probabilistic Storm Surge Graphics
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Storm Surge Watch/Warning Map
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Graphics
05.07Tropical Storm Beryl Forecast Discussion Number 29
05.07Tropical Storm Beryl Wind Speed Probabilities Number 29
More »